|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600119853 |
|
最近更新日期: Date of Last Refreshed on: |
2026-03-04 15:51:47 |
|
注册时间: Date of Registration: |
2026-03-04 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
术前3.0T MRI多参数定量评估对肩袖修复术后再撕裂风险的预测价值 |
|
Public title: |
The Predictive Value of Preoperative 3.0-Tesla MRI Multiparameter Quantitative Assessment for the Risk of Retear After Rotator Cuff Repair |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
术前3.0T MRI多参数定量评估对肩袖修复术后再撕裂风险的预测价值 |
|
Scientific title: |
The Predictive Value of Preoperative 3.0-Tesla MRI Multiparameter Quantitative Assessment for the Risk of Retear After Rotator Cuff Repair |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
严栋航 |
研究负责人: |
严栋航 |
|
Applicant: |
Donghang Yan |
Study leader: |
Donghang Yan |
|
申请注册联系人电话: Applicant telephone: |
+86 15657927858 |
研究负责人电话: Study leader's telephone: |
+86 579 88181188 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
327998413@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
327998413@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
浙江省金华市浦阳县恒昌大道158号 |
研究负责人通讯地址: |
浙江省金华市浦阳县恒昌大道158号 |
|
Applicant address: |
No. 158, Hengchang Avenue, Pujiang County, Jinhua City, Zhejiang Province, China |
Study leader's address: |
158 Hengchang Avenue, Puyang County, Jinhua City, Zhejiang Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
浦江县人民医院 |
||
|
Applicant's institution: |
Pujiang County People's Hospital? |
||
|
研究负责人所在单位: |
浦江县人民医院 |
||
|
Affiliation of the Leader: |
Pujiang County People's Hospital? |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
浦人医伦审2025研第063号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
浦江县人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Pujiang people's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-09-28 00:00:00 |
||
|
伦理委员会联系人: |
刘彩虹 |
||
|
Contact Name of the ethic committee: |
Liu CaiHong |
||
|
伦理委员会联系地址: |
浙江省金华市浦阳县恒昌大道158号 |
||
|
Contact Address of the ethic committee: |
158 Hengchang Avenue, Puyang County, Jinhua City, Zhejiang Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 579 88181181 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
2687753759@qq.com |
|
研究实施负责(组长)单位: |
浙江省浦江县人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Pujiang County People's Hospital? |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
浙江省金华市浦阳县恒昌大道158号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
158 Hengchang Avenue, Puyang County, Jinhua City, Zhejiang Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自选课题(自筹) |
||||||||||||||||||||||
|
Source(s) of funding: |
Independent Research Project (Self-Funded) |
||||||||||||||||||||||
|
Target disease: |
Tendon tear? |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
本研究通过建立术前MRI定量预测模型,可精准识别再撕裂高风险患者,从而优化手术适应症选择,避免对高风险患者进行无效手术。这有助于减少术后并发症和再次手术率,降低医疗成本。 |
||||||||||||||||||||||
|
Objectives of Study: |
By establishing a preoperative MRI-based quantitative prediction model, this study can accurately identify patients at high risk of re-tear, thereby optimizing the selection of surgical candidates and avoiding ineffective operations for high-risk individuals. This approach helps reduce postoperative complications and reoperation rates, leading to lower healthcare costs.? |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.明确诊断为肩袖撕裂,并且计划进行关节镜下肩袖修复术; |
||||||||||||||||||||||
|
Inclusion criteria |
1.Patients must have a confirmed diagnosis of a rotator cuff tear and be scheduled for arthroscopic rotator cuff repair; 2.Patients must have no contraindications for MRI, be able to complete the examination successfully, and have image quality that meets the requirements for analysis; 3.Patients must have relatively complete pre-operative, intra-operative, and follow-up data to ensure the analyzability of the data; 4.Patients must voluntarily participate in the study and sign the informed consent form. |
||||||||||||||||||||||
|
排除标准: |
1.既往肩关节手术史; |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Patients with a history of previous shoulder surgery; 2.Patients with severe glenohumeral osteoarthritis; 3.Patients with shoulder inflammation, tumor, or metabolic bone disease; 4.Patients with massive irreparable rotator cuff tear; 5.Patients with significant systemic disease uncontrolled; 6.Patients with MRI contraindication or poor image quality; 7.Patients unable to cooperate with follow-up after surgery; 8.Patients who refuse to sign the informed consent form. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-06-01 00:00:00至 To 2027-05-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-09-25 00:00:00 至 To 2026-08-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究结束后6个月,临床试验公共管理平台http://www.medresman.org.cn/ |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Six months after the end of the study, Clinical Trial Public Management Platform http://www.medresman.org.cn/ |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例数据用Excel表格记录,统计分析采用SPSS软件进行。研究数据锁库后6个月内,将在上述平台共享脱敏后的原始数据。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case data were recorded in Excel, and statistical analysis was performed using SPSS software. The de-identified raw data will be shared on the aforementioned platform within 6 months after database lock. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |